UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 118

Sortiert nach

Modified Positive and Negative Syndrome Scale-A Journey of a Thousand Miles Starts With the First Step

JAMA psychiatry (Chicago, Ill.), 2020-10, Vol.77 (10), p.999

2020

Volltextzugriff (PDF)

Antidepressant medications have evolved in terms of speed of onset of efficacy: How can we best measure antidepressant treatment response?

Current medical research and opinion, 2024-04, Vol.40 (4), p.701-703

2024

Volltextzugriff (PDF)

Design of a real-world, prospective, longitudinal, observational study to compare vortioxetine with other standard of care antidepressant treatments in patients with major depressive disorder: a PatientsLikeMe survey

BMC psychiatry, 2023-06, Vol.23 (1), p.464-464, Article 464

2023

Volltextzugriff (PDF)

High glycemic index diet as a risk factor for depression: analyses from the Women's Health Initiative

The American journal of clinical nutrition, 2015-08, Vol.102 (2), p.454-463

2015

Volltextzugriff (PDF)

Ameliorating treatment-refractory depression with intranasal ketamine: potential NMDA receptor actions in the pain circuitry representing mental anguish

CNS spectrums, 2016-02, Vol.21 (1), p.12-22

2016

Volltextzugriff (PDF)

Network Analysis Indicates That Avolition Is the Most Central Domain for the Successful Treatment of Negative Symptoms: Evidence From the Roluperidone Randomized Clinical Trial

Schizophrenia bulletin, 2020-07, Vol.46 (4), p.964-970

2020

Volltextzugriff (PDF)

High glycemic index and glycemic load diets as risk factors for insomnia: analyses from the Women’s Health Initiative

The American journal of clinical nutrition, 2020-02, Vol.111 (2), p.429-439

2020

Volltextzugriff (PDF)

Prenatal exposure to lead, delta-aminolevulinic acid, and schizophrenia: further evidence

Environmental health perspectives, 2008-11, Vol.116 (11), p.1586-1590

2008

Volltextzugriff (PDF)

Potential stigma associated with inclusion of the psychosis risk syndrome in the DSM-V: An empirical question

Schizophrenia research, 2010-07, Vol.120 (1), p.42-48

2010

Volltextzugriff (PDF)

Statistical validation of the criteria for symptom remission in schizophrenia: preliminary findings

BMC psychiatry, 2007-07, Vol.7 (1), p.35-35, Article 35

2007

Volltextzugriff (PDF)

Functioning and Cognition in Patients with Schizophrenia After Initiating Treatment with Aripiprazole Lauroxil: Secondary Outcomes and Post Hoc Analysis

Innovations in clinical neuroscience, 2024-01, Vol.21 (1-3), p.43-51

2024

Volltextzugriff (PDF)

A qualitative investigation of the Montgomery-Åsberg depression rating scale: discrepancies in rater perceptions and data trends in remote assessments of rapid-acting antidepressants in treatment resistant depression

Frontiers in psychiatry, 2024-05, Vol.15, p.1289630-1289630

2024

Volltextzugriff (PDF)

Short Sleep Duration as a Risk Factor for Hypercholesterolemia: Analyses of the National Longitudinal Study of Adolescent Health

Sleep (New York, N.Y.), 2010-07, Vol.33 (7), p.956-961

2010

Volltextzugriff (PDF)

Public Stigma Associated With Psychosis Risk Syndrome in a College Population: Implications for Peer Intervention

Psychiatric services (Washington, D.C.), 2013-03, Vol.64 (3), p.284-288

2013

Volltextzugriff (PDF)

Recommendations for selection and adaptation of rating scales for clinical studies of rapid-acting antidepressants

Frontiers in psychiatry, 2023-06, Vol.14, p.1135828-1135828

2023

Volltextzugriff (PDF)

Positive and Negative Syndrome Scale (PANSS) Training: Challenges, Solutions, and Future Directions

Innovations in clinical neuroscience, 2017-12, Vol.14 (11-12), p.77-81

2017

Volltextzugriff (PDF)

Fetal Environment and Schizophrenia

Environmental health perspectives, 2005-09, Vol.113 (9), p.1239-1242

2005

Volltextzugriff (PDF)

Sleep Duration Associated with Mortality in Elderly, but not Middle-Aged, Adults in a Large US Sample

Sleep (New York, N.Y.), 2008-08, Vol.31 (8), p.1087-1096

2008

Volltextzugriff (PDF)

Cross-Validation of the Arabic Mini International Neuropsychiatric Interview, Module K, for Diagnosis of Schizophrenia and the Arabic Positive and Negative Syndrome Scale

Journal of psychopathology and behavioral assessment, 2020-03, Vol.42 (1), p.139-149

2020

Volltextzugriff (PDF)

Autism Behavior Inventory: A Novel Tool for Assessing Core and Associated Symptoms of Autism Spectrum Disorder

Journal of child and adolescent psychopharmacology, 2017-11, Vol.27 (9), p.814

2017

Volltextzugriff (PDF)

Pharmacotherapy of cognitive deficits in schizophrenia

CNS spectrums, 2014-04, Vol.19 (2), p.142-156

2014

Volltextzugriff (PDF)

Paternal occupational lead exposure and offspring risks for schizophrenia

Schizophrenia research, 2016-10, Vol.176 (2-3), p.560-565

2016

Volltextzugriff (PDF)

Prenatal Lead Exposure, δ-Aminolevulinic Acid, and Schizophrenia

Environmental health perspectives, 2004-04, Vol.112 (5), p.548-552

2004

Volltextzugriff (PDF)

Paternal age related schizophrenia (PARS): Latent subgroups detected by k -means clustering analysis

Schizophrenia research, 2011-05, Vol.128 (1), p.143-149

2011

Volltextzugriff (PDF)

Time-to-pregnancy and risk of schizophrenia

Schizophrenia research, 2010-05, Vol.118 (1), p.76-80

2010

Volltextzugriff (PDF)

1 – 25 von 118

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(109)
Mit Volltextzugriff
(105)

Publikationsform

Sprache

Englisch
(118)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Science & Technology
(65)
Life Sciences & Biomedicine
(64)
Psychiatry
(51)
Humans
(50)
Schizophrenia
(38)
Female
(33)
Male
(30)
Adult
(27)
Middle Aged
(23)
Risk Factors
(20)
Biological And Medical Sciences
(17)
Medical Sciences
(16)
Psychology. Psychoanalysis. Psychiatry
(15)
Neurosciences & Neurology
(14)
Psychiatric Status Rating Scales
(14)
Psychopathology. Psychiatry
(13)
Psychoses
(13)
Adult And Adolescent Clinical Studies
(12)
Clinical Trials
(12)
Reproducibility Of Results
(12)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Modified Positive and Negative Syndrome Scale-A Journey of a Thousand Miles Starts With the First Step

Antidepressant medications have evolved in terms of speed of onset of efficacy: How can we best measure antidepressant treatment response?

Design of a real-world, prospective, longitudinal, observational study to compare vortioxetine with other standard of care antidepressant treatments in patients with major depressive disorder: a PatientsLikeMe survey

High glycemic index diet as a risk factor for depression: analyses from the Women's Health Initiative

Ameliorating treatment-refractory depression with intranasal ketamine: potential NMDA receptor actions in the pain circuitry representing mental anguish

Network Analysis Indicates That Avolition Is the Most Central Domain for the Successful Treatment of Negative Symptoms: Evidence From the Roluperidone Randomized Clinical Trial

High glycemic index and glycemic load diets as risk factors for insomnia: analyses from the Women’s Health Initiative

Prenatal exposure to lead, delta-aminolevulinic acid, and schizophrenia: further evidence

Potential stigma associated with inclusion of the psychosis risk syndrome in the DSM-V: An empirical question

Statistical validation of the criteria for symptom remission in schizophrenia: preliminary findings

Functioning and Cognition in Patients with Schizophrenia After Initiating Treatment with Aripiprazole Lauroxil: Secondary Outcomes and Post Hoc Analysis

A qualitative investigation of the Montgomery-Åsberg depression rating scale: discrepancies in rater perceptions and data trends in remote assessments of rapid-acting antidepressants in treatment resistant depression

Short Sleep Duration as a Risk Factor for Hypercholesterolemia: Analyses of the National Longitudinal Study of Adolescent Health

Public Stigma Associated With Psychosis Risk Syndrome in a College Population: Implications for Peer Intervention

Recommendations for selection and adaptation of rating scales for clinical studies of rapid-acting antidepressants

Positive and Negative Syndrome Scale (PANSS) Training: Challenges, Solutions, and Future Directions

Fetal Environment and Schizophrenia

Sleep Duration Associated with Mortality in Elderly, but not Middle-Aged, Adults in a Large US Sample

Cross-Validation of the Arabic Mini International Neuropsychiatric Interview, Module K, for Diagnosis of Schizophrenia and the Arabic Positive and Negative Syndrome Scale

Autism Behavior Inventory: A Novel Tool for Assessing Core and Associated Symptoms of Autism Spectrum Disorder

Pharmacotherapy of cognitive deficits in schizophrenia

Paternal occupational lead exposure and offspring risks for schizophrenia

Prenatal Lead Exposure, δ-Aminolevulinic Acid, and Schizophrenia

Paternal age related schizophrenia (PARS): Latent subgroups detected by k -means clustering analysis

Time-to-pregnancy and risk of schizophrenia

Suchergebnisse filtern